Neurological Paraneoplastic Syndromes in most Common Cancers in Poland
Authors:
- Julia PiątkiewiczJPJulia Piątkiewicz
- Maria KrzyżanowskaMKMaria Krzyżanowska
- Karen GłogowskaKGKaren Głogowska
- Mikołaj WojtasMWMikołaj Wojtas
- Mateusz SztybórMSMateusz Sztybór
- Monika MaleszewskaMMMonika Maleszewska
- Aleksandra ŻmijewskaAŻAleksandra Żmijewska
- Gabriela NowakGNGabriela Nowak
- Marcin KapicaMKMarcin Kapica
- Wojciech KopaczWKWojciech Kopacz
Open Access
- 22 March 2024
- journal article
- research article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 64, 93-105
Abstract
INTRODUCTION: Paraneoplastic Neurological Syndromes (PNS) represent a heterogeneous group of diseases associated with the presence of neoplasm. The appearance of PNS can precede cancer diagnosis. The estimated frequency amongst cancer patients is about 1%. Malignant tumors represent a serious health problem and are the second leading cause of death in Poland. The aim of this study is to collect information about PNS focusing on cancers mostly diagnosed in Polish adults. REVIEW METHODS: The analysis was conducted based on information regarding PNS gathered from PubMed and Google Scholar within the context of selected cancers. THE STATE OF KNOWLEDGE: PNS develop from an autoimmune reaction in which onconeural antibodies are produced. The recent classification divides PNS to high risk, indicating a likely paraneoplastic origin and intermediate risk, if this association is less evident. Diagnosis is difficult and usually relies on exclusion methods. The symptoms described are non-specific and the diagnostic process may require the involvement of various specialists. The main approaches include cancer treatment, especially tumor removal and immunotherapy, which in certain may prove to be effective. SUMMARY: Although PNS is relatively rare, its detectability has recently increased. Many syndromes are especially associated with lung cancer (mainly small cell carcinoma). Breast and prostate cancers have also shown associations with certain syndromes. They can present with nonspecific symptoms related to different organ systems. Awareness and understanding of this phenomenon can be helpful amongst many specialists.Keywords
This publication has 21 references indexed in Scilit:
- Paraneoplastic neurological syndromes: a practical approach to diagnosis and managementPractical Neurology, 2021
- Updated Diagnostic Criteria for Paraneoplastic Neurologic SyndromesNeurology Neuroimmunology & Neuroinflammation, 2021
- Paraneoplastic neurological syndrome: an evolving storyNeuro-Oncology Practice, 2021
- Paraneoplastic syndromes in small cell lung cancerJournal of Thoracic Disease, 2020
- Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatmentSeminars in Diagnostic Pathology, 2019
- Posterior cord syndrome: Demographics and rehabilitation outcomesThe Journal of Spinal Cord Medicine, 2019
- Paraneoplastic neuronal intermediate filament autoimmunityNeurology, 2018
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- Rhombencephalitis / Brainstem EncephalitisCurrent Neurology and Neuroscience Reports, 2011
- Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic CancerMedicine, 2003